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Abstract
Honey is increasingly valued for its antibacterial activity, but knowledge regarding the mechanism of action is still
incomplete. We assessed the bactericidal activity and mechanism of action of RevamilH source (RS) honey and manuka
honey, the sources of two major medical-grade honeys. RS honey killed Bacillus subtilis, Escherichia coli and Pseudomonas
aeruginosa within 2 hours, whereas manuka honey had such rapid activity only against B. subtilis. After 24 hours of
incubation, both honeys killed all tested bacteria, including methicillin-resistant Staphylococcus aureus, but manuka honey
retained activity up to higher dilutions than RS honey. Bee defensin-1 and H2O2 were the major factors involved in rapid
bactericidal activity of RS honey. These factors were absent in manuka honey, but this honey contained 44-fold higher
concentrations of methylglyoxal than RS honey. Methylglyoxal was a major bactericidal factor in manuka honey, but after
neutralization of this compound manuka honey retained bactericidal activity due to several unknown factors. RS and
manuka honey have highly distinct compositions of bactericidal factors, resulting in large differences in bactericidal activity.
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Introduction
Antibiotic-resistant bacteria pose a very serious threat to public
health. Resistance not only is a major problem in hospitals;
resistant bacteria are now recognized among various groups in the
community, such as pig-breeders, and in cattle [1–3]. Frequencies
of bacterial resistance are increasing worldwide while very few new
antibiotics are being developed [4,5]. Therefore alternative
antimicrobial strategies are urgently needed.
For thousands of years honey has been used for treatment of
wounds and as a gastrointestinal remedy [6,7]. Honey has broad-
spectrum activity against pathogenic and food-spoiling bacteria
[8–11]. The potent in vitro activity of honey against antibiotic-
resistant bacteria [8] and its successful application in treatment of
chronic wound infections not responding to antibiotic therapy [12]
evoked interest in honey as antibacterial agent in modern
medicine. RevamilH and manuka medical-grade honey have
potent antibacterial activity [9,13] and are approved for
application in wound management. RS honey, the source for
RevamilH, is produced under standardized conditions in green-
houses. The factors responsible for the bactericidal activity of this
honey are the high sugar concentration, H2O2, the 1,2-dicarbonyl
compound methylglyoxal (MGO), the cationic antimicrobial
peptide bee defensin-1 and the low pH [14].
Manuka honey is produced from the manuka bush (Leptospermum
scoparium) indigenous to New Zealand and Australia. Exceptionally
high concentrations of the antibacterial compound MGO have
been found in manuka honey [15,16], but the contribution this
and possible other compounds to the bactericidal activity of
manuka honey is still unknown.
Incomplete knowledge of the antibacterial factors in honey and
the contribution of these factors to the bactericidal activity hamper
general applicability of honey. In the current study we determined
the levels of all established honey antibacterial factors in RS and
manuka honey and assessed the contribution of these factors to the
bactericidal activity of both honeys against food-spoiling and
pathogenic bacteria, including methicillin-resistant Staphylococcus
aureus. We demonstrate that RS and manuka honey have highly
distinct compositions of bactericidal factors, resulting in substantial
differences in bactericidal activity. We show that in addition to
MGO several other factors contribute substantially to the
bactericidal activity of manuka honey. The implications of these
findings for prudent application in medicine and for the potential
use of honey in food preservation are discussed.
Methods
Honey
Unprocessed RevamilH source (RS) honey was kindly provided
by Bfactory Health Products (Rhenen, The Netherlands). Non-
sterilized UMFTM 16+ Active manuka honey was purchased from
Nature’s nectar Limited (Surrey, UK). To study the contribution
of the sugars to the bactericidal activity of honey, a solution with
a sugar composition similar to that of honey was prepared
(333 g/kg glucose, 385 g/kg fructose, 73 g/kg sucrose and 62 g/
kg maltose).
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17709
Microorganisms
Bactericidal activity of honey was assessed against Bacillus subtilis
ATCC6633, Escherichia coli ML-35p [17], Pseudomonas aeruginosa
PAO-1 (ATCC 15692) and against methicillin-resistant S. aureus
(MRSA) strain AMC201 [14].
Quantification of H2O2 in honey
H2O2 concentrations that had accumulated in diluted honey
were determined quantitatively as described previously [18]. In
brief, 40 ml samples of honey were added to 135 ml reagent,
consisting of 50 mg/ml o-dianisidine (Sigma-Aldrich, St. Louis,
MI, USA) and 20 mg/ml horseradish peroxidase type IV (Sigma-
Aldrich, St. Louis, MI, USA) in 10 mM phosphate buffer pH 6.5.
After 5 min. of incubation at room temperature, reactions were
stopped by addition of 120 ml 6 M H2SO4 and absorption at
540 nm was measured. H2O2 concentrations were calculated
using a calibration curve of 2-fold serial dilutions of H2O2 ranging
from 2200 to 2.1 mM.
Methylglyoxal (MGO) quantification and neutralization
assay
Reduced glutathione (Sigma-Aldrich, St. Louis, MI, USA) was
added to diluted honey to a final concentration of 15 mM, and
conversion of MGO to S-D-lactoyl-glutathione (SLG) was initiated
by addition of 0.5 U/ml glyoxalase I (Sigma-Aldrich, St. Louis,
MI, USA). We previously determined that the bactericidal activity
of a solution containing 20 mM MGO was completely neutralized
by conversion to SLG [14]. The amount of MGO converted to
SLG was determined using the extinction coefficient of SLG of
3.37 mM21 at 240 nm [19]. As a control for complete conversion
of MGO in honey, SLG formation was assessed for 40% honey
solutions spiked with 10 mM of exogenous MGO.
Analysis of bee defensin-1 in honey
Bee defensin-1 was separated from other honey bactericidal
factors and analysed as described previously [14]. In brief, 15 ml
of 20% (v/v) honey was centrifuged in a 5 kDa molecular weight
cut-off Amicon Ultra-15 tube (Millipore, Waters, Milford, MA,
USA) at 40006g for 45 min. at room temperature. The ,5 kDa
filtrate was collected, and the .5 kDa retentate, where bee
defensin-1 would be retained, was subsequently washed three
times in the filter tube with 15 ml of demineralized water and
concentrated to 0.4 ml. Duplicate samples of retentate equivalent
to 150 ml of undiluted honey were subjected to native acid-urea
polyacrylamide gel electrophoresis (AU-PAGE). Bee defensin-1
was subsequently visualized by parallel Coomassie-staining and by
a B. subtilis overlay assay.
Liquid bactericidal assay
Bactericidal activity of honey was quantified in 100 ml volume
liquid tests, in polypropylene microtiterplates (Costar, Corning,
NY, USA). For each experiment, a 50% (v/v) stock solution of
honey was freshly prepared in incubation buffer containing
10 mM phosphate buffer pH 7.0 supplemented with 0.03% (w/
v) trypticase soy broth (TSB; Difco, Detroit, MI, USA). Bacteria
from logarithmic phase cultures in TSB were washed twice with
incubation buffer and used at a final concentration of
16106 CFU/ml, based on optical density. Plates were incubated
at 37uC on a rotary shaker at 150 rpm. At indicated time points,
duplicate 10 ml aliquots of undiluted and 10-fold serially diluted
incubations of three independent incubations were plated on blood
agar. Bacterial survival was quantified after overnight incubation
at 37uC. The detection level of this assay is 100 CFU/ml. To
assess the contribution of H2O2 and cationic compounds to the
bactericidal activity of honey, 600 U/ml bovine liver catalase
(Sigma-Aldrich, St. Louis, MI, USA) and 0.025% (w/v) sodium
polyanetholesulfonate (SPS; Sigma-Aldrich, St. Louis, MI, USA),
respectively, were added to incubations. Since bee defensin-1 is the
only cationic bactericidal compound present in RS honey [14],
addition of SPS to this honey specifically neutralizes bee defensin-
1. The incubation buffer did not affect the pH of the
concentrations of honey used in our experiments. A 1 M NaOH
solution was used to titrate honey solutions to pH 7.0.
Ultrafiltration of honey components
Fifteen ml of 20% (v/v) honey was centrifuged in a 5 kDa
molecular weight cut-off Amicon Ultra-15 tube (Millipore, Waters,
Milford, MA, USA) at 40006g for 45 min. at room temperature.
The ,5 kDa filtrate was collected, and the .5 kDa retentate was
subsequently washed three times in the filter tube with 15 ml of
demineralized water and concentrated to 0.4 ml.
Bacterial overlay assay
To visualize the antibacterial activity of bee defensin-1 from
honey, a bacterial overlay assay was used. Amounts of .5 kDa
honey retentate equivalent to 150 ml honey were separated by acid
urea polyacrylamide gel electrophoresis (AU-PAGE) [20]. Gels
were either stained with PAGE-Blue (Fermentas, Vilnius,
Lithuania) or washed 368 min. in 10 mM phosphate buffer
pH 7.0 for a bacterial overlay assay. After washing, the gel was
incubated for 3 hours at 37uC on B. subtilis-inoculated nutrient-
poor agarose to allow components to diffuse into the agarose. For
this agarose, a B. subtilis inoculum suspension was prepared as
described for the liquid bactericidal assay. Bacteria (107 CFU)
were mixed with 20 ml nutrient-poor agar (0.03% (w/v) TSB in
10 mM sodium phosphate buffer, pH 7.0, with 1% low EEO
agarose [Sigma-Aldrich, St. Louis, MI, USA]) of 45uC, and
immediately poured into 10610-cm culture plates. Subsequently,
the gel was removed and the agarose was overlayed with 20 ml of
double-strength nutrient agarose (6% TSB, 1% Bacto-agar, 45uC),
and plates were incubated overnight at 37uC. Antibacterial activity
resulting in zones devoid of bacterial growth is visualized as dark
zones in a dark-field image.
Results
Bactericidal activity of RS and manuka honey
The bactericidal activity of RS and manuka honey was tested
against the food-spoiling bacterium Bacillus subtilis and against the
wound pathogens methicillin-resistant Staphylococcus aureus (MRSA),
Escherichia coli and Pseudomonas aeruginosa. We determined the
maximal dilution of honey which reduced bacterial survival 1000-
fold after 2 and 24 hours of incubation, using 2-fold serial dilutions
of 40% (v/v) honey. After 2 h up to 13.363.3-fold diluted RS
honey killed B. subtilis, whereas manuka honey could only be 2.5-
fold diluted (Fig. 1). After 24 hours, RS and manuka honey had
potent activity against B. subtilis, up to 10- and 20-fold dilution,
respectively. Neither RS nor manuka honey had bactericidal
activity against MRSA after 2 hours. After 24 hours RS and
manuka honey did kill MRSA, at dilutions of up to 10- and 80-
fold, respectively (Fig. 1). E. coli and P. aeruginosa were killed by RS
honey diluted 2.5-fold at 2 hours incubation, while manuka honey
lacked rapid activity against these bacteria (Fig.1). After 24 hours
RS honey had bactericidal activity against both bacteria up to 5-
fold dilution, and manuka honey killed E. coli and P. aeruginosa up
to dilution of 10- and 5-fold, respectively (Fig. 1). Overall, RS
honey clearly had more potent bactericidal activity than manuka
Bactericidal Activity of Medical-Grade Honeys
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after 2 hours of incubation, while manuka was the most potent
honey after 24 hours.
Characterization of H2O2, MGO and bee defensin-1 in RS
and manuka honey
We assessed the levels of the predominant bactericidal factors
in RS and manuka honey, i.e. MGO, H2O2, and bee defensin-1.
RS and manuka honey contained 0.2560.01 mM and
10.9461.70 mM MGO, respectively (Fig. 2A). Hydrogen perox-
ide is produced by the Apis mellifera (honey bee) glucose oxidase
enzyme upon dilution of honey [18,21]. RS honey at a
concentration of 40% (v/v) accumulated up to 3.4760.25 mM
H2O2 in 24 hours, while no H2O2 was detected in diluted manuka
honey (Fig. 2B).
Bee defensin-1 can be visualized by parallel Coomassie-staining
and a B. subtilis overlay assay after separation of proteins of the
.5 kDa fraction of honey by native acid-urea PAGE [14]. After
gel electrophoresis, bee defensin-1 in the .5 kDa retentate of RS
honey produced a clear zone of growth inhibition of B. subtilis in a
gel overlay assay (Fig. 2C). In a similar amount of manuka honey
retentate no bee defensin-1 was detected either by Coomassie-
staining or in a gel overlay assay (Fig. 2C). In a radial diffusion
assay with B. subtilis an amount of RS honey retentate equivalent
to 0.5 ml honey produced a zone of bacterial growth inhibition,
while in an up to 20-fold larger amount of manuka retentate no
antibacterial activity was observed (not shown).
Factors contributing to the bactericidal activity of
manuka honey after 24 hours
We previously determined the contribution of H2O2, bee
defensin-1, MGO and the low pH to the bactericidal activity of RS
honey after 24 hours of incubation [14], which is summarized in
Table 1. In manuka honey we did not detect H2O2 or bee
defensin-1, but this honey contained an approximately 40-fold
higher concentration of MGO compared to RS honey. To assess
the contribution of MGO to the bactericidal activity of manuka
honey after 24 hours, and to reveal potential other factors, we
neutralized MGO by conversion to the non-bactericidal
S-lactoylglutathione and assessed the remaining bactericidal
activity. Neutralization of MGO reduced the activity against
MRSA to a level identical to that of a honey-equivalent sugar
solution (Fig. 3), indicating that MGO was responsible for the
potent activity of manuka honey against MRSA. With MGO
neutralized, 8- and 2-fold higher concentrations of manuka honey
were required to kill B. subtilis and P. aeruginosa, respectively (Fig. 3).
MGO-neutralized manuka honey still had more activity than a
sugar solution against these species, and the activity of manuka
honey against E. coli was not affected by neutralization of MGO
(Fig. 3). This indicated the presence of other bactericidal factors
beside MGO.
The polyanionic compound sodium polyanetholesulphonate
(SPS) neutralizes cationic compounds. Addition of SPS to MGO-
neutralized manuka honey abolished the residual activity against
P. aeruginosa (Fig. 3) implying that this activity was due to cationic
compound(s). As manuka honey does not contain detectable
amounts of bee defensin-1, other cationic bactericidal compo-
nent(s) must be present. Activity against B. subtilis and E. coli was
also reduced but not abolished when SPS was added (Fig. 3),
which indicates the contribution of both cationic and non-cationic
factors to the non-MGO bactericidal activity of manuka honey.
When the pH of MGO- and cationic compound-neutralized
manuka honey was adjusted from 3.9 to 7.0, all remaining activity
against E. coli was abolished. Activity against B. subtilis was reduced,
Figure 1. Bactericidal activity of RS and manuka honey.
Indicated bacteria were incubated with serial dilutions of RS or manuka
honey, starting at 40% honey. After 2 h (white bars) and 24 h (hatched
bars) of incubation bacteria were quantitatively cultured. The bars
represent the highest dilutions of honey causing a 1000-fold reduction
in numbers of CFU relative to the initial inocula. The values are mean 6
SEM of independent triplicate incubations.
doi:10.1371/journal.pone.0017709.g001
Figure 2. Comparison of levels of MGO, H2O2 and bee defensin-1 in RS and manuka honey. (A) Concentration of MGO in RS and manuka
(Man.) honey, determined spectrophotometrically after its conversion to S-lactoylglutathione by glyoxalase I treatment. (B) H2O2 accumulation over
time in 40% (v/v) RS (squares) and manuka honey (triangles). (C) Proteins were concentrated from honey by ultrafiltration with a 5 kDa molecular
weight cut-off membrane. Amounts of.5 kDa retentate equivalent to 150 ml of undiluted honey, and 3 mg of lysozyme (lys.) as a reference, were run
in duplicate on a single native acid-urea PAGE gel to separate cationic proteins. One half of the gel was Coomassie-stained (left), the other was used
for a bacterial overlay assay with B. subtilis (right). Since a dark-field image was obtained, growth inhibition of the bacteria due to the presence of
antibacterial proteins appears as a dark zone.
doi:10.1371/journal.pone.0017709.g002
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but was still substantial (Fig. 3). So, the low pH was responsible for
all non-cationic bactericidal activity of MGO-neutralized manuka
honey against E. coli, while still other non-cationic bactericidal
factor(s) were involved in activity against B. subtilis. As expected,
addition of catalase – which neutralizes H2O2 – did not affect the
bactericidal activity of manuka honey (not shown), since this honey
did not contain detectable levels of H2O2 (Fig 2).
In summary, the high sugar concentration, MGO, low pH and
as yet unidentified cationic factor(s) and non-cationic bactericidal
factor(s) contributed to the bactericidal activity of manuka honey
as recorded after 24 h.
Factors contributing to the rapid bactericidal activity of
RS and manuka honey
In figure 1 we showed that RS honey had rapid activity (within
2 hours) against B. subtilis, E. coli and P. aeruginosa while manuka
honey exerted rapid activity only against B. subtilis. We
subsequently assessed the contribution of individual factors to this
rapid bactericidal activity. The entire B. subtilis inoculum was
killed within 2 hours by 5% RS honey (Fig. 4A). When bee
defensin-1 was neutralized by addition of SPS, 40% RS honey was
required to kill B. subtilis. Subsequent neutralization of H2O2
reduced the activity of RS honey to that of a honey-equivalent
sugar solution (Fig. 4A). So, bee defensin-1 and to a lesser extent
H2O2, were the major factors involved in rapid activity of RS
honey against B. subtilis.
Neutralization of bee defensin-1 did not affect the activity of
RS honey against E. coli or P. aeruginosa (Fig. 4A). After
neutralization of H2O2 the activity of RS honey against E. coli
was reduced to that of a sugar solution and the activity of 40%
RS honey against P. aeruginosa was reduced to a level at which the
numbers of CFU were only about 1-log lower than after
incubation in sugar (Fig. 4A). Titration of honey to pH 7
Figure 3. Contribution of MGO to the bactericidal activity of manuka honey. The indicated bacteria were incubated in various
concentrations (v/v) of manuka honey in incubation buffer (squares), in manuka with addition of glyoxalase I (triangles) or glyoxalase I and SPS
without (diamonds) or with adjustment of the pH to 7.0 (asterisks), or in a honey-equivalent sugar solution (circles). After 24 hours, numbers of
surviving bacteria were determined.
doi:10.1371/journal.pone.0017709.g003
Table 1. Contribution of bactericidal factors to activity of RS and manuka honey.
H2O2
bee
defensin-1 MGO pH
additional
cationic
additional
non-cationic
RSa Man RS Man RS Man RS Man RS Man RS Man
B. subtilis rapidb - rapid - slow rapid slow rapid - rapid - rapid
MRSA slow - slow - slow slow - - - - - -
E. coli rapid - slow - slow slow - slow - slow - slow
P. aeruginosa rapid - slow - slow slow slow - - slow - -
aRS: RS honey, Man: manuka honey.
bContribution is defined as $1 log reduction in numbers of CFU after 2 hours (rapid) or 24 hours (slow) of incubation.
doi:10.1371/journal.pone.0017709.t001
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abolished all residual activity against P. aeruginosa (not shown). So,
in different combinations, bee defensin, H2O2, sugars and the low
pH contributed to the rapid activity of RS honey against specific
bacterial species.
Concentrations of $30% manuka honey were required for
rapid activity against B. subtilis (Fig. 4B). Neutralization of MGO in
manuka honey reduced but did not abolish this rapid activity
(Fig. 4B). The remaining activity was not affected by titration to
pH 7 (Fig. 4B) or addition of catalase (not shown), but this activity
was further reduced but not abolished by addition of SPS (Fig. 4B).
Both the cationic and non-cationic factor(s) involved in this rapid
activity are unknown.
Discussion
General applicability of honey as antimicrobial agent requires
safe preparations, knowledge of the composition of antibacterial
factors and standardized antibacterial activity. Medical-grade
honeys are gamma-irradiated to eradicate bacterial spores which
may be present in raw honey. RevamilH and manuka medical-
grade honey are approved as a medical product for wound care.
Manuka honey obtained from manuka trees (Leptospermum
scoparium) in New Zealand and Australia has large batch-to-batch
variation in antibacterial activity [13]. Medical-grade manuka
honey often carries a UMFTM (Unique Manuka Factor) value
representing its antimicrobial activity. This value is based on
activity against S. aureus in an agar diffusion assay. Standardization
of RS honey, the source for RevamilH, is based on a controlled
production process in greenhouses. We have previously shown that
the bactericidal activity of RevamilH honey against B. subtilis varies
by less than a factor two for eleven batches of honey [9], but the
antibacterial activity of this honey is not routinely assessed.
In medicine, honey may be used either for treatment of
infection or as antibacterial prophylaxis. Honey applied to wounds
is diluted by wound exudate, so the active compounds need to be
present in high concentrations. Treatment of infections particu-
larly requires rapid bactericidal activity, whereas prophylactic
application demands sustained and not necessarily very rapid
bactericidal activity. We therefore assessed the rapid and slow
bactericidal activity of RS and manuka honey, i.e. the activity after
2 and 24 hours of incubation, respectively. RS honey had much
more potent rapid activity than manuka honey against B. subtilis,
E. coli and P. aeruginosa. Both RS and manuka honey lacked rapid
activity against MRSA. With respect to slow bactericidal activity,
manuka honey was more potent than RS honey, most notably
against MRSA and B. subtilis.
RS honey contains relatively high levels of bee defensin-1 and
H2O2 and only a minor amount of MGO, whereas the opposite is
true for manuka honey. The contribution of these compounds for
rapid and slow bactericidal activity of RS and manuka honey is
summarized in Table 1. The main conclusion is that these honeys
exert bactericidal activity through entirely different sets of
compounds, resulting in distinct bactericidal properties. MGO
contributed substantially to the activity of manuka honey against S.
aureus and B. subtilis but not against E. coli and P. aeruginosa. The
activity against these latter bacteria involved compounds other
than MGO including as yet unidentified cationic and non-cationic
compounds. In earlier studies before the discovery of MGO, acidic
[22] and phenolic compounds [23,24] were isolated from manuka
honey. The contribution of these factors to the bactericidal activity
was questioned at that time, since their concentrations in manuka
honey were far too low to account for all observed activity [25]. It
is possible that acidic and phenolic compounds are responsible for
the non-MGO bactericidal activity of manuka honey. Bee
defensin-1 and H2O2 were responsible for most of the rapid
activity of RS honey and the absence of these compounds explains
the limited rapid bactericidal activity of manuka honey.
Honeys show wide variation in their capacity to produce H2O2;
some honeys – including the manuka honey used in our study - do
not accumulate H2O2 at all [18,26]. Several causes for the absence
of H2O2 in honey have been proposed. Factors known to affect
H2O2 accumulation are the inactivation of glucose oxidase due to
exposure to excess heat or light [27,28] degradation of H2O2 by
catalase originating from nectar [29], and chemical scavenging
Figure 4. Factors contributing to rapid bactericidal activity of
RS and manuka honey. (A) RS honey; bacteria were incubated for
2 hours in various concentrations (v/v) of RS honey in incubation buffer
(squares), with either catalase (asterisks), SPS (triangles) or both
(diamonds) added, or in sugar solution (circles). (B) Manuka honey; B.
subtilis was incubated for 2 hours in various concentrations of manuka
honey in incubation buffer (squares), with successive addition of
glyoxalase I (triangles, top up), SPS (triangles, top down), and titration
to pH 7.0 (asterisks), or in sugar solution (circles).
doi:10.1371/journal.pone.0017709.g004
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[30]. Another explanation for the variation in H2O2 accumulation
in honeys could be differences in levels of glucose oxidase. To our
knowledge no studies have been performed to assess the
concentration of glucose oxidase in honey.
Bee defensin-1 is secreted in honey by the honey bee
hypopharyngeal gland [14], but we did not detect bee defensin-1
in manuka honey. Secretions of the hypopharyngeal gland are
used for production of royal jelly and honey [31,32]. The amount
of bee defensin-1 in royal jellies (therein referred to as ‘royalisin’)
obtained from different apiaries varies strongly [33], with some
samples completely devoid of this peptide. This implies that bee
defensin-1 expression in hypopharyngeal glands and/or the
amount of gland secretions added may vary strongly. This could
also explain the difference in bee defensin-1 levels in RS and
manuka honey.
Recently, the 1,2-dicarbonyl compound MGO was identified as
antibacterial compound present in exceptionally high levels in
manuka honey [15,16]. In general, MGO can be formed from
sugars during heat-treatment or prolonged storage of carbohy-
drate-containing foods and beverages [34]. MGO in manuka
honey however is formed by conversion of dihydroxyacetone
(DHA) present at exceptionally high concentrations in the nectar
of manuka trees (Leptospermum scoparium) [35]. It is unknown how
DHA is formed in nectar and why it is present in such large
amounts in manuka trees. Concentrations of MGO in fermented
milk products, wine, beer and roasted coffee have been reported to
be in the range of 3 to 47 mg/kg, while up to 828 mg/kg
(16.1 mM), has been found in manuka honey [15,16]. MGO is a
reactive metabolite that can exert toxic effects [36]. Manuka
honey has a long history of safe use, but nowadays batches of
manuka honey with maximized levels of MGO are selected for
medical and nutritional use. Concerns regarding potential toxicity
of dietary MGO in honey and the effects on wound healing have
been expressed by others [16,37] and this remains to be
investigated.
The antibacterial properties of honey, or of individual honey
components, could also be interesting for application in food
technology, e.g. for food preservation or as functional food
ingredients. It has for instance been reported that honey can
inhibit opportunistic bacterial growth in milk [38]. We show that
the food spoilage bacterium B. subtilis is highly susceptible to
manuka honey, and also Bacillus cereus is effectively killed by this
honey (data not shown). Since manuka honey retains bactericidal
activity against food-spoiling bacilli up to very high dilution, this
honey has better potential than RS honey for food preservation.
Lack of standardization of antibacterial activity and incomplete
knowledge of the active components are major limitations for the
application of honey in medicine. The antibacterial activity of
medical-grade manuka honey is commonly assessed by an agar
diffusion assay with S. aureus [13]. This method has several major
limitations. Firstly, antibacterial activity against a single bacterial
species is not representative for activity against other species, since
different species have varying susceptibility to honey and its
antibacterial factors. We show for instance, that E. coli and P.
aeruginosa are substantially less susceptible to manuka honey than S.
aureus and B. subtilis. Secondly, in the agar diffusion assay the
activity of honey is estimated by the size of the growth inhibition
zone. Obviously, the size of such zones not only depends on the
antimicrobial activity, but also on the rate of diffusion of
antibacterial factors through the agar matrix. Honey with potent
antibacterial activity due to compounds with relatively high
molecular weight may thus erroneously be characterized as having
low activity. Thirdly, the agar diffusion test does not discriminate
between growth inhibiting and bactericidal activity and does not
allow quantification of bactericidal activity or kinetics of killing.
To assess the potential of honey for treatment of infection it is
important to discriminate between bacteriostatic and bactericidal
activity, and to quantify the latter activity. This is also highly
relevant for application of honey or honey-derived components in
food preservation. In the current study, these limitations were
overcome by the use of a quantitative liquid bactericidal assay with
a panel of representative bacterial species.
Detailed analysis of antibacterial factors and bactericidal activity
against a representative panel of bacteria is essential to
characterize honeys. Such characterization will allow the produc-
tion of standardized honeys with defined antibacterial activity,
contributing to their applicability for medical, nutritional and food
preservation purposes.
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